All Stories

  1. Tonantzitlolone is a nanomolar potency activator of transient receptor potential canonical 1/4/5 channels

    Article • British Journal of Pharmacology, June 2018, Wiley

    Dr Hussein N Rubaiy

  2. The therapeutic agents that target ATP-sensitive potassium channels

    Article • Acta Pharmaceutica, January 2016, De Gruyter

    Dr Hussein N Rubaiy

  3. Therapeutic agents that target KATP channels in diabetes and cardiovascular diseases

    Article • Acta Pharmaceutica, January 2015, De Gruyter

    Dr Hussein N Rubaiy, Michael Bergin